Curriculum Vitae. Education: Italian Degree of Doctor in Biology, 1972, University of L Aquila (Italy)

Size: px
Start display at page:

Download "Curriculum Vitae. Education: Italian Degree of Doctor in Biology, 1972, University of L Aquila (Italy)"

Transcription

1 Curriculum Vitae Name: Pasquale Battista Date and place of birth: 17 st October 1949, Pescara, ITALY Nationality: ITALIAN Married, 1 daughter Official address, phone and fax numbers: G. d Annunzio University of Chieti-Pescara School of Human Movement Sciences Department of Human Movement Sciences Chieti Campus Via dei Vestini CHIETI ITALY Telephone: Telefax: battista@unich.it Education: Italian Degree of Doctor in Biology, 1972, University of L Aquila (Italy) Career/Employment: Specialization: Pathology Teacher of practical laboratory exercises (School of Medicine, Chieti University Italy Assistant Professor in Pathology (School of Medicine, Chieti University - Italy) Associate Professor of Pathology (School of Medicine, Chieti University - Italy) 2001-present Full Professor of Pathology (School of Human Movement Sciences, Chieti University Italy) Stages John Fogarty Visiting Fellow, Laboratory of Immunobiology, National Cancer Institute, NIH, Bethesda, MD, USA 1986 Guest Worker, Laboratory of Immunobiology, National Cancer Institute, NIH, Bethesda, MD, USA 1

2 Main teaching activity "Istitution of General Pathology" (School of Medicine, University of Chieti-Pescara Italy) "Patholgy and General Physiopathology (School of Medicine, Chieti University Italy) "General Pathology" (School of Pharmacy, University of Chieti-Pescara Italy) 2001-presente " Pathology and General Physiopathology (School of Human Movement Sciences, Chieti University Italy) Supervisor Responsable of the PhD course in Scienze del Sistema Motorio (School of Human Movement Sciences, University of Chieti-Pescara Italy) Specialization: current research interests: (i) genetic alterations of genes predisposing to familial and/or hereditary forms of breast and colorectal cancers. Genetic instability in intronic or exonic mono-ditri-quadrinucleotide repeats of target genes associated with cancer progression. Genetic alterations of the Insulin Receptor Substrates 1 and 2 involved in type 2 diabetes. Scientific Affiliations Italian Society of Pathology Italian Society of Oncology American Association for Cancer Research Italian Association study Familial and Ereditary Gastrointestinal cancers (A.I.F.E.G.) Member of the Scientific and Organizing Committee of: 2 nd National Congress of AIFEG Chieti, 2003 Vice-President of the A.I.F.E.G. Scientific Publications: HUMAN GENE MUTATIONS: Breast/Ovarian Cancer. Aceto G, Di Fulvio P, Stuppia L, Veschi S, Contegiacomo A, Pensabene M, Cama A, Curia MC, Palka G, Mariani-Costantini R, Battista P. Hum Genet, 110: ,

3 THE ITALIAN MULTI-CENTRE PROJECT ON EVALUATION OF MRI AND OTHER IMAGING MODALITIES IN EARLY DETECTION OF BREAST CANCER INSUBJECTS AT HIGH RISK. Podo F, Sardanelli F, Canese R, Battista P et al. J Exp Clin Cancer Res, 21: , 2002 MEDICINA MOLECOLARE E STORIA DELLA MEDICINA:DALLA PALEOPATOLOGIA ALLA GENETICA DELLE POPOLAZIONI. Verginelli F, Ottini L, Esposito DL, Cama A, Battista P, Tiranni R, Zagaglia K, Mariani-Costantini R, Fornaciari G. Medicina nei Secoli: Arte e Scienza, 14: , 2002 A NOVEL T608R MISSENSE MUTATION IN INSULIN RECEPTOR SUBSTRATE-1 IDENTIFIED IN A SUBJECT WITH TYPE 2 DIABETES IMPAIRS METABOLIC INSULIN SIGNALING. Esposito DL, Li Y, Vanni C, Mammarella S, Veschi S, Della Loggia F, Mariani-Costantini R, Battista P, Quon MJ, Cama A. J Clin Endocr & Metab, 88: , 2003 VARIATION OF THE HYPERVARIABLE REGION-1 OF MITOCHONDRIAL DNA IN CENTRAL -EASTERN ITALY. Verginelli F, Donati F, Coia V, Boschi I, Palmirotta R, Battista P, Mariani-Costantini R,Destro- Bisiol G. J Forensic Sci, 48: 1-3, 2003 BRAC-1 AND BRCA-2 MUTATIONS IN BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY. Stuppia L, Di Fulvio P, Aceto G, Pintor S, Veschi S, Gatta V, Colosimo A, Cianchetti E, Cama A, Mariani-Costantini R, Battista P, Palka G. Hum Mutat, 635: 1-8, 2003 MOLECULAR ANALYSIS OF BRCA1/BRCA2 MUTATIONS IN 68 FAMILIES WITH BREAST OR OVARIAN CANCER FROM CENTRAL ITALY. Stuppia L, Di Fulvio P, Pintor S, Aceto G, Veschi S, Gatta V, Colosimo A, Cianchetti E, Cama A, Battista P, Mariani-Costantini R, Palka G. Recent Advances Research Updates, 4: , 2003 CORRELATION BETWEEN PHENOTYPE AND MICROSATELLITE INSTABILITY IN HNPCC: IMPLICATIONS FOR GENETIC TESTING. Palmirotta R, Matera S, Curia MC, Aceto G, El Zhobi B, Verginelli F, Guadagni F, Casale V, Stigliano V, Messerini L, Mariani-Costantini R, Battista P, Cama A. Familial Cancer, 3: , 2004 IDENTIFICATION ON A NOVEL MUTATION AFFECTING DOMAIN V OF THE 23S rrna IN HELICOBACTER PYLORI. 3

4 Toracchio S, Aceto GM, Mariani-Costantini R, Battista P, Marzio L. Helicobacter, , 2004 GENETIC EVIDENCE THAT JUVENILE NASOPHARYNGEAL ANGIOFIBROMA IS AN INTEGRAL FAP-TUMOR. Valanzano R, Curia MC, Aceto G, Veschi S, De Lellis L, Catalano T, La Rocca G, Battista P, Cama A, Tonelli, Mariani-Costantini R. Gut, , 2005 MUTATIONS IN THE P53 AND KI-RAS GENES, MICROSATELLITE INSTABILITY AND SITE OF TUMOR ORIGIN IN COLORECTAL CANCER. Catalano T, Curia MC, Aceto G, Verginelli F, Cascinu S, Cama A, Mariani-Costantini, Teti D, Battista P. Oncology Reports, 14: , 2005 MUTATIONS OF APC AND MYH IN UNRELATED ITALIAN PATIENTS WITH ADENOMATOUS POLYPISIS COLI. Aceto G, Curia MC, Veschi S, De Lellis L, Mammarella S, Catalano T, Stuppia L, Palka G, Valanzano R, Tonelli F, Casale V, Stigliano V, Cetta F, Battista P, Mariani-Costantini R, Cama A. Hum Mutat, #841:1-8, 2005 (On line) COMBINED USE OF MLPA AND NON-FLUORESCENT MULTIPLEX PCR ANALYSIS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (NFMP-HPLC) FOR THE DETECTION OF GENOMIC REARRANGEMENTS. De Lellis L, Curia MC, Catalano T, De Toffol S, Bassi C, Mareni C, Bertario L, Battista P, Mariani-Costantini R, Radice P, Cama A. Hum Mutat, 27: , 2006 BRCA1 AND BRCA2 STATUS IN A CENTRL SUDANESE SERIES OF BREAST CANCER PATIENTS: INTERACTIONS WITH GENETIC, ETHNIC AND REPRODUCTIVE FACTORS. Awadelkarim KD, Aceto G, Veschi S, Elhag A, Morgano A, Mohamadani AA, Eltayeb EA, Abuidris D, Di Gioacchino M, Battista, P, Verginelli F, Cama A, Elwali NE, Mariani-Costantini R. Breast Cancer Res Treat, 102: , 2007 BALANCE BETWEEN ENDOSCOPIC AND GENETIC INFORMATION IN THE CHOICE OF ILEORECTAL ANASTOMOSIS FOR FAMILIAL ADENOMATOUS POLYPOSIS. Valanzano R, Ficari F, Curia MC, Aceto G, Veschi S, Cama A, Battista P, Tonelli F. Journal of Surgical Oncology 95:28-33, 2007 OBESITY MODIFIES THE EFFECTS OF THE ASP905TYR VARIANT OF PPP1R3A ON RISK OF TYPE 2 DIABETES AND INSULIN SENSITIVITY. Mammarella S, Creati B, Staniscia T, Manzoli L, Di Valerio A, Aceto G, Romano R, Giovanni Cama, Capani F, Consoli A, Vitacolonna E, Esposito-Del Puente A, Battista P, Della Loggia F, Mariani-Costantini R, Quon MJ, Cama A. Diabetes Obes Metab, 5: ,

5 HIGH PREVALENCE OF BRCA1 DELETIONS IN BRCAPro-POSITIVE PATIENTS WITH HIGH CARRIER PROBABILITY. Veschi S, Aceto G, Scioletti AP, Gatta V, Palka G, Cama A, Mariani-Costantini R, Battista P, Calò V, Barbera F, Bazan V, Russo A, Stuppia L. Annals of Oncology, 18(suppl.6): 86-92,

CURRICULUM VITAE Name: Diana Liberata Esposito Citizenship: Australian and Italian Work address: University G. d Annunzio Chieti-Pescara, Aging

CURRICULUM VITAE Name: Diana Liberata Esposito Citizenship: Australian and Italian Work address: University G. d Annunzio Chieti-Pescara, Aging CURRICULUM VITAE Name: Diana Liberata Esposito Citizenship: Australian and Italian Work address: University G. d Annunzio Chieti-Pescara, Aging Research Center, Room 568, Via Luigi Polacchi, 11 66100 Chieti,

More information

Dal germinale al somatico nella identificazione di tumori ereditari

Dal germinale al somatico nella identificazione di tumori ereditari Modena 18-19 novembre 2010 Dal germinale al somatico nella identificazione di tumori ereditari Laura Ottini Tendencies to develop cancer can be inherited Fletcher & Houlston, 2010 Cancer is a genetic disease

More information

Risk Assessment and Screening Tools November 17, 2010

Risk Assessment and Screening Tools November 17, 2010 Risk Assessment and Screening Tools November 17, 2010 Cecelia Bellcross Posted in the Resource Repository at: http://www.resourcerepository.org/documents/2073/riskassessmentandscreeningtool s/ Cecelia

More information

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Irene Catucci 1,2,12, Paolo Verderio 3,12, Sara Pizzamiglio 3,12, Siranoush Manoukian 4, Bernard Peissel 4, Daniela Zaffaroni

More information

BRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010

BRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Inheritance patterns of BRCA1/2 Cancer Risks for men with BRCA1/2 mutations Risk management recommendations for men with BRCA1/2 mutations

More information

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013 Hereditary Ovarian cancer: BRCA1 and BRCA2 Karen H. Lu MD September 22, 2013 Outline Hereditary Breast and Ovarian Cancer (HBOC) BRCA1/2 genes How to identify What it means to you What it means to your

More information

Ovarian Cancer Genetic Testing: Why, When, How?

Ovarian Cancer Genetic Testing: Why, When, How? Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine

More information

CURRICULUM VITAE ROBERTO GIACOMELLI MD, PhD

CURRICULUM VITAE ROBERTO GIACOMELLI MD, PhD CURRICULUM VITAE ROBERTO GIACOMELLI MD, PhD NAME Roberto Giacomelli TITLE Full Professor of Rheumatology, University of L Aquila, School of Medicine, L Aquila, Italy NATIONALITY Italian ADDRESS Permanent:

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance Program (CMAP) on the requirements for

More information

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls? Giovanni Luca Scaglione, PhD ------------------------ Laboratory of Clinical Molecular Diagnostics and Personalized Medicine, Institute

More information

Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes

Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes Genetic Testing for Lynch Syndrome/Colorectal Cancer and Polyposis Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO 09/01/2011

More information

E UROPEAN CURRICULUM VITAE FORMAT

E UROPEAN CURRICULUM VITAE FORMAT E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Address VALENTINA GUARNERI University of Padova Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche Istituto Oncologico Veneto

More information

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS -

Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - January 2005 SCIENTIFIC BACKGROUND Breast cancer is considered to be one of the most prevalent cancer in women. The overall

More information

CURRICULUM VITAE Rosella Visintin. Assistant professor of SEMM (European School of Molecular Medicine). IFOM-IEO Campus Milan - Italy

CURRICULUM VITAE Rosella Visintin. Assistant professor of SEMM (European School of Molecular Medicine). IFOM-IEO Campus Milan - Italy CURRICULUM VITAE Rosella Visintin Positions: Since 2006 Since July 2005 Assistant professor of SEMM (European School of Molecular Medicine). IFOM-IEO Campus Milan - Italy Junior group leader at the European

More information

Breast cancer and the role of low penetrance alleles: a focus on ATM gene

Breast cancer and the role of low penetrance alleles: a focus on ATM gene Modena 18-19 novembre 2010 Breast cancer and the role of low penetrance alleles: a focus on ATM gene Dr. Laura La Paglia Breast Cancer genetic Other BC susceptibility genes TP53 PTEN STK11 CHEK2 BRCA1

More information

Date and place of birth 28th January 1958; Moretta (Cuneo) (Italy). Two children

Date and place of birth 28th January 1958; Moretta (Cuneo) (Italy). Two children ANNA SAPINO Date and place of birth 28th January 1958; Moretta (Cuneo) (Italy). Two children MEDICAL EDUCATION: Medical Degree, University of Turin (1982); Professional specialization in Pathological Anatomy

More information

The Department of Vermont Health Access Medical Policy

The Department of Vermont Health Access Medical Policy State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 [Phone] 802-879-5903 Williston, VT 05495-2807 [Fax] 802-879-5963 www.dvha.vermont.gov Agency of Human Services The Department

More information

Future Directions in Cancer Research What does is mean for medical physicists and AAPM?

Future Directions in Cancer Research What does is mean for medical physicists and AAPM? Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman

More information

BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients

BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients A. Al-Ansari 1, K. Al-Mawali 2, B. Al-Bahrani 3, M.S. Al-Moundhri 3 1 Department of Biology, College of Science, 2 Department of Pathology,

More information

Resumen Curricular de los Profesores. Jesse Boehm

Resumen Curricular de los Profesores. Jesse Boehm Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub

More information

How Can Institutions Foster OMICS Research While Protecting Patients?

How Can Institutions Foster OMICS Research While Protecting Patients? IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice

More information

TRACKS GENETIC EPIDEMIOLOGY

TRACKS GENETIC EPIDEMIOLOGY Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that

More information

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary

More information

Lucia Migliore. Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice

Lucia Migliore. Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice Lucia Migliore Transfer of recent evidences concerning genetic and epigenetic risk factors of complex diseases on clinical practice Dipartimento di Ricerca Traslazionale e Nuove Tecnologie in Medicina

More information

Curriculum Vitae - Sara Gandini

Curriculum Vitae - Sara Gandini Curriculum Vitae - Sara Gandini Academic information 2004 PHD IN CANCER STUDIES at the University of Birmingham (Public Health), UK. Thesis: Meta-Analysis in Cancer Epidemiology. 1995 MASTER OF SCIENCE

More information

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011 Medical Policy Manual Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Date of Origin: January 27, 2011 Section: Genetic Testing Last Reviewed Date: May 2015 Policy No: 02 Effective Date:

More information

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How

More information

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond Arturo Anguiano MD, FACMG International Medical Director, Medical Affairs Vice Chairman, Genetics; Medical Director,

More information

Department of Gastrointestinal Surgery Hospital Clínic i Provincial de Barcelona Villarroel, 170 Barcelona 08036

Department of Gastrointestinal Surgery Hospital Clínic i Provincial de Barcelona Villarroel, 170 Barcelona 08036 Personal Information Name: Address: Dr. Antonio M. Lacy Fortuny Chief of Gastrointestinal Surgery Hospital Clínic, Barcelona Department of Gastrointestinal Surgery Hospital Clínic i Provincial de Barcelona

More information

Cancer Genetic Counseling

Cancer Genetic Counseling Cancer Genetic Counseling Guest Expert: Ellen, MS Director of the Yale Cancer Center Cancer Genetic Counseling Program www.wnpr.org www.yalecancercenter.org I am Bruce Barber and this is Yale Cancer Center

More information

Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers

Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers J. Appl. Genet. 44(3), 2003, pp. 419-423 Short communication Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers Bohdan GÓRSKI,

More information

Cancer: Genetic testing can save lives

Cancer: Genetic testing can save lives Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who

More information

DR. MARIO RAMPA. Instructor at Regional course of Early Defibrillation. S.S.U.Em 118, Via dell Eremo, 9-23900 Lecco - Italy

DR. MARIO RAMPA. Instructor at Regional course of Early Defibrillation. S.S.U.Em 118, Via dell Eremo, 9-23900 Lecco - Italy CURRICULUM VITAE DR. MARIO RAMPA PERSONALINFORMATION Name Address Phone Mario Rampa E-mail Nationality Date of birth Italian June 22 nd, 1979 WORK EXPERIENCE From 01/2001 to 07/2006 General Surgery III

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence

More information

GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE

GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology

More information

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae Ariela Benigni Biol.Sci.D., Ph.D. Curriculum Vitae Personal Data Name: Date and place of birth: Citizenship: E-mail: Ariela Benigni December 16, 1955 - Bergamo, Italy Italian ariela.benigni@marionegri.it

More information

Breast Cancer s Link to Ovarian Cancer: It s in Your Genes. foundationforwomenscancer.org

Breast Cancer s Link to Ovarian Cancer: It s in Your Genes. foundationforwomenscancer.org Breast Cancer s Link to Ovarian Cancer: It s in Your Genes foundationforwomenscancer.org There are now more than 2.6 million women in America who have been diagnosed with breast cancer. A very small fraction

More information

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD Importance of Family History Increasing awareness of

More information

ITT Advanced Medical Technologies - A Programmer's Overview

ITT Advanced Medical Technologies - A Programmer's Overview ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: High/Moderate Risk Panel Sequence

More information

Mediterranean School of Oncology

Mediterranean School of Oncology Mediterranean School of Oncology Organized and supported by: CINBO Consorzio Interuniversitario Nazionale per la Bioncologia HIGHLIGHTS IN THE MANAGEMENT OF COLORECTAL CANCER, February 1-2, 2007 Domus

More information

BRCA1 & BRCA2 GeneHealth UK

BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 GeneHealth UK BRCA1 & BRCA2 What is hereditary breast cancer? Cancer is unfortunately very common, with 1 in 3 people developing cancer at some point in their lifetime. Breast cancer occurs

More information

UNIVERSITA CATTOLICA DEL SACRO CUORE POLICLINICO UNIVERSITARIO A.GEMELLI CLINICA UROLOGICA Largo F. Vito, 1 00168 Roma, Italy

UNIVERSITA CATTOLICA DEL SACRO CUORE POLICLINICO UNIVERSITARIO A.GEMELLI CLINICA UROLOGICA Largo F. Vito, 1 00168 Roma, Italy E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name BASSI PIERFRANCESCO Address UNIVERSITA CATTOLICA DEL SACRO CUORE POLICLINICO UNIVERSITARIO A.GEMELLI CLINICA UROLOGICA Largo F. Vito, 1 00168

More information

Curriculum Vitae. Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian

Curriculum Vitae. Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian Curriculum Vitae Personal information Name: Anna Surname: Puggina Date of Birth: 24/01/1987 Place of Birth: Dolo (VE), Italy Citizenship: Italian Contact information Address: Via San Pio X 7/a, 35122,

More information

Curriculum Vitae Eric S. Miguelino, M.D. Staff Toxicologist, Department of Public Health, Food and Drug Branch, State of California

Curriculum Vitae Eric S. Miguelino, M.D. Staff Toxicologist, Department of Public Health, Food and Drug Branch, State of California updated 02/10 Curriculum Vitae Eric S. Miguelino, M.D. Staff Toxicologist, Department of Public Health, Food and Drug Branch, Office Address: Department of Public Health Food and Drug Branch Medical Device

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

Screening guidelines tool

Screening guidelines tool Screening guidelines tool Disclaimer: This material is intended as a general summary of screening and management recommendations; it is not intended to be comprehensive. Colorectal cancer (CRC) screening

More information

Delivering the Promise of Genetic and Genomic Medicine. From Research to Clinical Care:

Delivering the Promise of Genetic and Genomic Medicine. From Research to Clinical Care: A m e r i c a n C o l l e g e o f M e d i c a l G e n e t i c s a n d G e n o m i c s Tr a n s l a t i n g G e n e s I n t o H e a l t h From Research to Clinical Care: Delivering the Promise of Genetic

More information

Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare

Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università

More information

American Cancer Society Extramural Grants

American Cancer Society Extramural Grants Page: 1 Graduate Scholarships in Cancer Nursing Practice (GSCNP) GSCNP-14-118-01 Abbott, Linda, MSN MENTOR: Hooke, Mary C., PhD, RN School of Nursing Graduate Scholarship in Cancer Nursing Practice 07/01/2014

More information

Lesson Plan: Genetic Testing and Hereditary Cancer

Lesson Plan: Genetic Testing and Hereditary Cancer Lesson Plan: Genetic Testing and Hereditary Cancer OVERVIEW This lesson plan is designed to be used with the film In the Family, which explores issues related to genetic testing and the difficult decisions

More information

Prognostic and Predictive Factors in Oncology. Mustafa Benekli, M.D.

Prognostic and Predictive Factors in Oncology. Mustafa Benekli, M.D. Prognostic and Predictive Factors in Oncology Mustafa Benekli, M.D. NCI Definitions ESMO Course -Essentials of Medical Oncology -Istanbul 2 Prognostic factor: NCI Definition A situation or condition, or

More information

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in

More information

Genetic Testing for Familial Adenomatous Polyposis and MYH-Associated Polyposis (Lynch Syndrome)

Genetic Testing for Familial Adenomatous Polyposis and MYH-Associated Polyposis (Lynch Syndrome) Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer

patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer patient guide BRCA1 and BRCA2 Genetic Testing for Hereditary Breast and Ovarian Cancer What is hereditary cancer? Cancer affects many people in the U.S.: breast cancer affects 1 in 8 women and ovarian

More information

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: 2.02.06 CATEGORY: Laboratory Test

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR HEREDITARY BRCA MUTATIONS. POLICY NUMBER: 2.02.06 CATEGORY: Laboratory Test MEDICAL POLICY SUBJECT: GENETIC TESTING FOR, 10/15/15 PAGE: 1 OF: 12 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical

More information

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources Appendix 2 Molecular Biology Core Curriculum Websites and Other Resources Chapter 1 - The Molecular Basis of Cancer 1. Inside Cancer http://www.insidecancer.org/ From the Dolan DNA Learning Center Cold

More information

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach Kerry C. Councilman, MD Assistant Professor University of Colorado Denver Goals: BRAF Mutation

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

Prostate Cancer Risk Epidemiology and Genetics. Robert F. Marschke, Jr., M.D. November 2, 2013

Prostate Cancer Risk Epidemiology and Genetics. Robert F. Marschke, Jr., M.D. November 2, 2013 Prostate Cancer Risk Epidemiology and Genetics Robert F. Marschke, Jr., M.D. November 2, 2013 PROSTATE CANCER RISK FACTORS Age The risk of prostate cancer rises rapidly after age 50 years PROSTATE CANCER

More information

Genomic Medicine Education Initiatives of the College of American Pathologists

Genomic Medicine Education Initiatives of the College of American Pathologists Genomic Medicine Education Initiatives of the College of American Pathologists Debra G.B. Leonard, MD, PhD, FCAP Chair, Personalized Healthcare Committee, CAP Professor of Pathology, Weill Cornell Medical

More information

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort

More information

Overall teaching planning and Istitutional tasks Antonio Cuneo (Hematology), Giovanni Lanza (Pathology)

Overall teaching planning and Istitutional tasks Antonio Cuneo (Hematology), Giovanni Lanza (Pathology) Title of the programme "Normal and abnormal growth of tissues and organs", Discipline - Oncology Period June 2013 Teaching language English Maximum number of students 10 +10 Programme co-ordinators Contactperson

More information

Overview of testing for Lynch syndrome/hnpcc

Overview of testing for Lynch syndrome/hnpcc Overview of testing for Lynch syndrome/hnpcc This overview provides detailed information about interpreting MSI/IHC testing and genetic testing for Lynch syndrome/hnpcc. It is intended to be a reference

More information

Rilevanza dell innovazione tecnologica per la

Rilevanza dell innovazione tecnologica per la Rilevanza dell innovazione tecnologica per la ricerca traslazionale e la terapia in oncologia Ruggero De Maria Dipartimento di Ematologia Oncologia e Medicina Molecolare, Istituto Superiore di Sanità Translational

More information

Biotechnical Engineering (BE) Course Description

Biotechnical Engineering (BE) Course Description Biotechnical Engineering (BE) Course Description The major focus of the Biotechnical Engineering TM (BE) course is to expose students to the diverse fields of biotechnology including biomedical engineering,

More information

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide

BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide BRCA1 & BRCA2: Genetic testing for hereditary breast and ovarian cancer patient guide What is Hereditary? Breast cancer is the most common cancer in women in the U.S. (it affects about 1 in 8 women). Ovarian

More information

I tumori ereditari del tratto gastro-enterico: un overview sugli aspetti

I tumori ereditari del tratto gastro-enterico: un overview sugli aspetti I tumori ereditari del tratto gastro-enterico: un overview sugli aspetti psico-sociali Marco L. Bellani Francesca Carini Psicologia Clinica e Psico-Oncologia A.O. Ospedale di Circolo e Fondazione Macchi

More information

Human Genome Organization: An Update. Genome Organization: An Update

Human Genome Organization: An Update. Genome Organization: An Update Human Genome Organization: An Update Genome Organization: An Update Highlights of Human Genome Project Timetable Proposed in 1990 as 3 billion dollar joint venture between DOE and NIH with 15 year completion

More information

Genetic Mutations Cause Many Birth Defects:

Genetic Mutations Cause Many Birth Defects: Genetic Mutations Cause Many Birth Defects: What We Learned from the FORGE Canada Project Jan M. Friedman, MD, PhD University it of British Columbia Vancouver, Canada I have no conflicts of interest related

More information

Riesgo genético y familiar. Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid

Riesgo genético y familiar. Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid Riesgo genético y familiar Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid Cancer: An example of complex disease 80-85% of cancers Polygenic model (combination of X genes) Low penetrance

More information

Are You at Risk for Ovarian Cancer?

Are You at Risk for Ovarian Cancer? Are You at Risk for Ovarian Cancer? A Woman s Guide Read this brochure to learn more about ovarian cancer symptoms, risk factors and what you can do to reduce your risk. ALL WOMEN HAVE SOME RISK OF OVARIAN

More information

American Cancer Society Extramural Grants

American Cancer Society Extramural Grants Page: 1 Doctoral Training Grant in Oncology Social Work Renewal (DSWR) DSWR-14-087-03 Blinka, Marcela, MSW MENTOR: BrintzenhofeSzoc, Karlynn, MSW, DSW, PhD The Catholic University of America National Catholic

More information

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel P A T I E N T G U I D E Hereditary Breast Cancer Panels High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel B a y l o r M i r a c a G e n e t i c s L a b o r a t

More information

IMMEDIATE HOT LINE: Effective March 2, 2015

IMMEDIATE HOT LINE: Effective March 2, 2015 MEDICARE COVERAGE OF LABORATORY TESTING Please remember when ordering laboratory tests that are billed to Medicare/Medicaid or other federally funded programs, the following requirements apply: 1. Only

More information

October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892

October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies

More information

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function: Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic

More information

GENETICS AND GENOMICS IN NURSING PRACTICE SURVEY

GENETICS AND GENOMICS IN NURSING PRACTICE SURVEY GENETICS AND GENOMICS IN NURSING PRACTICE SURVEY Dear Registered Nurse: You are invited to take a survey that will evaluate primary issues in genetics and genomics. As the front line of care, nurses have

More information

Genetic Testing: Scientific Background for Policymakers

Genetic Testing: Scientific Background for Policymakers Genetic Testing: Scientific Background for Policymakers Amanda K. Sarata Specialist in Health Policy December 19, 2011 CRS Report for Congress Prepared for Members and Committees of Congress Congressional

More information

AGENDA. WP 2. Modernization of PhD regulation @ UP Leader: University of G. d Annunzio

AGENDA. WP 2. Modernization of PhD regulation @ UP Leader: University of G. d Annunzio Project name: Modernizing the 3rd cycle at the University of Prishtina and Developing a PhD Program at the Faculty of Economics Project number: 544188-TEMPUS-1-2013-1-XK-TEMPUS-JPCR AGENDA WP 2. Modernization

More information

How To Test For Hcv Pharmacogenetics

How To Test For Hcv Pharmacogenetics 1-09:47 Terapia antivirale e farmacogenomica [emilio.dimaria@unige.it] Dipartimento di Scienze della Salute Università di Genova SSD Genetica Medica EO di Genova 2-09:47 Pharmacogenomics [ or Pharmacogenetics?]

More information

Nancy E. Davidson, MD Johns Hopkins University. Breast Cancer

Nancy E. Davidson, MD Johns Hopkins University. Breast Cancer This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

L-M. LABORATORY INVESTIGATION London : Nature ISSN 0023-6837 70(1994)-88(2008); lac. 2005;2006;2008

L-M. LABORATORY INVESTIGATION London : Nature ISSN 0023-6837 70(1994)-88(2008); lac. 2005;2006;2008 L-M LABORATORY INVESTIGATION London : Nature ISSN 0023-6837 70(1994)-88(2008); lac. 2005;2006;2008 LANCET (THE) London : The Lancet ; Elsevier ISSN 0140-6736 2(1989)8672-8679; 336(1990)8727-372(2008);

More information

Undergraduate -10months scolarship

Undergraduate -10months scolarship Undergraduate -10months scolarship Programme Title. Module Code. Academic Level Module Title ECTS Module Start Dates: BA in Medicine 12.1 Undergraduate BA in Medicine 60 September 2014 BA in Dentistry

More information

Nuevas tecnologías basadas en biomarcadores para oncología

Nuevas tecnologías basadas en biomarcadores para oncología Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS

More information

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary

More information

Research Opportunities

Research Opportunities Below are various organizations that offer research opportunities for medical students. Please go to the websites listed for detailed information regarding the organization as well as the research program.

More information

Establishment of a Microsatellite Instability Education and Training Program in Cyprus

Establishment of a Microsatellite Instability Education and Training Program in Cyprus Establishment of a Microsatellite Instability Education and Training Program in Cyprus 2010-1-CY1-LEO05-00858 1 Information sur le projet Titre: Code Projet: Establishment of a Microsatellite Instability

More information

The University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015

The University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015 Permanent Health Funds for Higher Education (Fund 810) Permanent Health Funds will be assigned to schools to support health education, research programs, and infrastructure operations. Strategy F.1.2.,

More information

Molecular Diagnosis of Gastrointestinal Tumors

Molecular Diagnosis of Gastrointestinal Tumors Molecular Diagnosis of Gastrointestinal Tumors Zoltan Szentirmay National Institute of Oncology Center of Surgical and Molecular Tumor Pathology EEA and Norwegian Financial Mechanisms in Hungary, Development

More information

Good morning, Chairman Kingston, Ranking Member DeLauro, and distinguished. The Unique Role of Academic Medical Centers in Health Care Transformation

Good morning, Chairman Kingston, Ranking Member DeLauro, and distinguished. The Unique Role of Academic Medical Centers in Health Care Transformation Statement by Vivian S. Lee, M.D., Ph.D., M.B.A., Senior Vice President for Health Sciences, Dean of the School of Medicine, and CEO of University of Utah Health Care on FY 2015 Appropriations for the Department

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Preparing for the Collection and Use of External Family History and Genetic Test Result Data

Preparing for the Collection and Use of External Family History and Genetic Test Result Data Preparing for the Collection and Use of External Family History and Genetic Test Result Data HL7 - More Than You Think HIMSS March 5, 2013 Grant M. Wood Intermountain Healthcare Clinical Genetics Institute

More information

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer Contents Introduction: biology and medicine, two separated compartments What we need to know: - boring basics in DNA/RNA structure and overview of particular aspects of molecular biology techniques - How

More information

Europass Curriculum Vitae

Europass Curriculum Vitae Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address(es) dos Santos Rua Manuel Bernardes, n.º 29-A r/c 1200-251 Lisboa Telephone(s) (+351) 96 508 51 32 Fax(es) E-mail anacatarinasalves@gmail.com

More information

Robert Bristow MD PhD FRCPC

Robert Bristow MD PhD FRCPC Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research

More information

Umbrella Graduate Programs. A report from the Vanderbilt IGP after 13 years

Umbrella Graduate Programs. A report from the Vanderbilt IGP after 13 years Umbrella Graduate Programs A report from the Vanderbilt IGP after 13 years Interdisciplinary Graduate Program Biomedical Sciences Originated 1992 10 Departments/Programs Biochemistry Cell Biology Cancer

More information

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities

Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities Vincent A. Miller, M.D. Foundation Medicine, Inc. AACR Annual Meeting 2012 Current Concepts session

More information